US stocks fluctuate | BeiGene (ONC.US) rises by more than 3%, third-quarter revenue exceeds 10 billion, raises 2025 performance guidance.

According to the Zhixun Financial APP, on Thursday, BeiGene (ONC.US) rose more than 3%, reaching $332.26. The financial report shows that in the third quarter, BeiGene's quarterly revenue exceeded 10 billion, reaching 10.077 billion yuan, an increase of 41.1% year-on-year; product revenue continued to grow rapidly, reaching 9.954 billion yuan, an increase of 40.6% year-on-year. Thanks to the strong growth in the third quarter, BeiGene raised its full-year performance guidance for 2025, expecting full-year revenue to be between 36.2 billion and 38.1 billion yuan, adjusted from between 35.8 billion and 38.1 billion yuan.